Articles
RUOK? How to respond to someone who isn't OK
World Suicide Prevention Day prompts people from all walks of life to ask their loved ones what could be a life-saving question: are you ok? [ + ]
Buildings That Heal
Contributions from neuroscience in designing the built environment [ + ]
The Conversation - The link between smoking and mental health
A recent study suggested a causal association between smoking tobacco and developing psychosis or schizophrenia, building on research about the relationship between the use of substances and the risk of psychosis. While cannabis is one of the usual suspects, a potential link with tobacco will have come as a surprise to many. [ + ]
Bullying in the Workplace: The Conversation
Over a decade ago now, I read a research article that called bullying the “cancer” of the workplace. I’ve been wondering since then whether bullying is really serious enough to warrant that language - and what can be done about it. [ + ]
The Conversation on Medical Research in the Developing World
This article is part of a series The Conversation Africa is running on stem cell research and therapy. Read the rest of the series here. [ + ]
Yoga for Stroke Rehabilitation: The Conversation
One in six Australians will have a stroke in their lifetime. That’s about 51,000 strokes per year, or one every ten minutes. Worldwide, stroke is the second most common cause of premature death, after heart disease, and is the leading cause of disability among adults. [ + ]
Ethics in IVF Gender Selection: The Conversation
This article is part of a series The Conversation Africa is running on stem cell research and therapy. Read the rest of the series here. [ + ]
Cancer Drugs Will Become Terminal for Health Systems
Narcyz Ghinea, University of Sydney; Ian Kerridge, University of Sydney, and Wendy Lipworth, University of Sydney [ + ]
Meningococcal B Vaccine Rejected From PBS
The vaccine, which is currently recommended for infants at six weeks old plus two boosters, and 12 months old, and again at 15-19 years can cost up to $500 for a full dose including boosters. The government’s Pharmaceutical Benefits Advisory Committee has again rejected subsidising the vaccine on the PBS despite leaders in the field calling for the vaccine for the disease to be accessble to Australian families at a low price. [ + ]
Why People with HIV Volunteer for "Cure" Research
Jennifer Power, La Trobe University [ + ]
Medical Research Future Fund - A Nation-Building Opportunity
This article was published in our Spring 2014 edition of Australian Hospital and Healthcare Bulletin. In light of the Medical Research Future Fund (MRFF) passing Senate last week, we have republished it to remind you of the key issues under discussion. [ + ]
